A study by Zhang et al. (2020) has shown that MAO-B is one of the clinically important metabolism-related genes that can be considered a biomarker for lung adenocarcinoma diagnosis, monitoring, and prognosis [40]. This evidence concerns the gene MAOB and lung adenocarcinoma.